Yahoo
Amsterdam - Delayed Quote EUR

DSM-Firmenich AG (DSFIR.AS)

105.75 -3.20 (-2.94%)
As of 1:53:16 PM GMT+1. Market Open.
Chart Range Bar
Loading chart for DSFIR.AS
  • Previous Close 108.95
  • Open 107.60
  • Bid --
  • Ask --
  • Day's Range 105.40 - 107.95
  • 52 Week Range 55.22 - 109.85
  • Volume 219,925
  • Avg. Volume 685,466
  • Market Cap (intraday) 25.841B
  • Beta (5Y Monthly) 0.53
  • PE Ratio (TTM) --
  • EPS (TTM) -5.34
  • Earnings Date Jul 30, 2026
  • Forward Dividend & Yield 2.50 (2.30%)
  • Ex-Dividend Date May 11, 2026
  • 1y Target Est 96.47

DSM-Firmenich AG provides nutrition, health, and beauty solutions in Switzerland, the Netherlands, rest of Europe, the Middle East and Africa, North America, Latin America, China, and rest of Asia. The company operates through Perfumery & Beauty; Taste, Texture & Health; and Health, Nutrition & Care segments. The Perfumery & Beauty creates scents using natural, synthetic, and biotech ingredients. The Taste, Texture & Health segment provides food and beverages solutions, including flavors, natural extracts, and sugar reduction; and food enzymes, hydrocolloids, cultures, natural colorants, nutritional ingredients, and plant-based proteins. The Health, Nutrition & Care segment provides solutions for the early life nutrition, dietary supplement, pharmaceutical, medical nutrition, biomedical materials, and nutrition improvement markets. This segment also offers vitamins, nutritional lipids, minerals, carotenoids, botanical nutraceuticals, digestive enzymes, postbiotics, probiotics and prebiotics, and active pharmaceutical ingredients; biomedical solutions; and premix, market-ready, and personalized nutrition solutions, as well as expert services in regulatory affairs and nutrition. DSM-Firmenich AG was founded in 1902 and is based in Kaiseraugst, Switzerland.

www.dsm-firmenich.com

20,786

Full Time Employees

December 31

Fiscal Year Ends

Performance Overview

Trailing total returns as of 10/28/2026, which may include dividends or other distributions. Benchmark is AEX-Index (^AEX) .

YTD Return

DSFIR.AS
59.78%
AEX-Index (^AEX)
19.06%

1-Year Return

DSFIR.AS
48.30%
AEX-Index (^AEX)
16.21%

3-Year Return

DSFIR.AS
45.76%
AEX-Index (^AEX)
58.58%

5-Year Return

DSFIR.AS
6.42%
AEX-Index (^AEX)
39.45%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 2.39B
Earnings --
Profit Margin 0.00%

Q3

FY25

Q4

FY25

Q1

FY26

Q2

FY26

0
1B
2B
3B
0.0%

Analyst Insights

View More

Analyst Price Targets

68.00 Low
96.47 Average
105.75 Current
117.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
As of 10/26/2026
  • Market Cap

    26.62B

  • Enterprise Value

    31.13B

  • Trailing P/E

    68.91

  • Forward P/E

    26.00

  • PEG Ratio (current)

    --

  • Price/Sales (ttm)

    3.82

  • Price/Book (mrq)

    1.51

  • Enterprise Value/Revenue

    4.33

  • Enterprise Value/EBITDA

    9.87

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -15.23%

  • Return on Assets (ttm)

    1.23%

  • Return on Equity (ttm)

    1.87%

  • Revenue (ttm)

    9.05B

  • Net Income Avi to Common (ttm)

    324M

  • Diluted EPS (ttm)

    -5.34

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.31B

  • Total Debt/Equity (mrq)

    37.64%

  • Levered Free Cash Flow (ttm)

    -140.38M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: